Doral® acts selectively on the BZ1 receptor—unlike conventional benzodiazepines.1 BZ1 receptor selectivity permits effective hypnosis, while reducing side effects, including tolerance, common to nonselective benzodiazepines.1
- Doral is the only available benzodiazepine selective for the BZ1 receptor1
- BZ1 receptor selectivity offers the benefits of a hypnotic agent without many of the drawbacks of typical benzodiazepines1
- Doral binds preferentially to BZ1 receptors in the pons and lamina IV—regions that may be involved in the primary and secondary mechanisms of sedation and sleep2
Doral is a hypnotic benzodiazepine with a unique pharmacological profile2
References: 1. Kales A. Quazepam: hypnotic efficacy and side effects. Pharmacotherapy. 1990;10;(1):1-12. 2. Hilbert JM, Battista D. Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics. J Clin Psychiatry. 1991;52(suppl 9):21-26.